Bone Structure in Patients With Adult Onset Growth Hormone Deficiency Assessed Using High Resolution Peripheral Quantitative Computed Tomography

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

45 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-09-30

Study Completion Date

2019-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to assess bone geometry, bone compartment specific volumetric densities and micro-architecture as well as to evaluate non-invasive estimates of bone strength in patients with adult onset growth hormone deficiency.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Bone Structure and Strength Evaluated by Extreme-CT Scan Before and After Treatment of Hyper- and Hypothyroidism

NCT02005250

Hyperthyroidism Hypothyroidism

COMPLETED

Myeloproliferative Neoplasms and Bone Structure

NCT01816022

Polycythemia Vera Thrombocythemia, Essential Primary Myelofibrosis

UNKNOWN

Evaluation of Bone Architecture and Bone Strength in Adults With Hypophosphatasia (HPP)

NCT04181164

Hypophosphatasia (HPP)

UNKNOWN

Markers of Bone Status in Diabetes Mellitus (Type 1 and Type 2)

NCT01870557

Diabetes Mellitus Osteoporosis Osteopenia

COMPLETED

Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fracture

NCT02355340

Bone Mineral Density Childhood Cancer Survivors

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adult Onset Growth Hormone Deficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Growth hormone deficiency (GHD)

Pituitary patients with GHD

No interventions assigned to this group

healthy controls

Sex and age-matched healthy controls

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women diagnosed with Adult onset Growth Hormone Deficiency
* Age between 18-80
* Informed consent

Exclusion Criteria

* Competing bone disease (e.g.. Mb. Paget, myelomatosis, osteogenesis imperfecta, osteoporosis, primary hyperparathyroidism)
* Ongoing medical treatment affecting bone metabolism (eg. osteoporosis medications)
* Ongoing pregnancy or breast feeding

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No